Skip to main content

NHGRI Releases RFAs for $1,000 Genome

NEW YORK, Feb. 13 (GenomeWeb News) - The National Human Genome Research Institute today released two RFAs aimed at reducing the costs of sequencing a single, full-length mammalian genome to $1,000 - down from current average costs of $10 to $50 million per genome - by the end of a 10-year time frame.

 

One RFA will commit $6 million in FY2004 and $5 million in FY2005 to fund new or competitive continuation grants for the long-range development of new technologies that could meet the $1,000 goal. The other RFA will commit $8 million in FY2004 and $5 million in FY2005 to fund new or competitive continuation grants for shorter term goals of improving existing technologies to reduce costs by two orders of magnitude below current costs. Respondents to both RFAs can apply under the R21, R33, R01 or P01 granting mechanisms, with deadlines of April 15 and Oct. 15, 2004.

 

The RFAs gave several potential applications of cost reduction efforts, including: expanding comparative genomic analysis across species, applying human genetic variation studies to individual health care, and analyzing microbial genomes for food and environment monitoring.

 

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.